v3.26.1
Risks and Uncertainties - Narrative (Details) - EBP 002 - USD ($)
Dec. 31, 2025
Dec. 31, 2024
EBP, Risk and Uncertainty [Line Items]    
Benchmark threshold percentage 5.00%  
Investment, Identifier [Axis]: GlaxoSmithKline PLC ADR    
EBP, Risk and Uncertainty [Line Items]    
Fair Value of Investment $ 311,727,076 $ 239,533,600
GSK investment, as percent of total investments 3.12% 2.72%